Diabetes: SGLT2 inhibitors and diabetic ketoacidosis - a growing concern

Nat Rev Endocrinol. 2017 Aug;13(8):441-442. doi: 10.1038/nrendo.2017.77. Epub 2017 Jun 16.

Author

Guillermo E Umpierrez¹

Affiliation

¹ Division of Endocrinology, Metabolism, and Lipids, Emory University School of Medicine, 69 Jesse Hill Jr Drive, Atlanta, Georgia 30303, USA.

PMID: 28621337
DOI: 10.1038/nrendo.2017.77

No abstract available

Publication types

Research Support, N.I.H., Extramural
Comment

MeSH terms

Diabetes Mellitus, Type 2
Diabetic Ketoacidosis*
Humans
Hypoglycemic Agents
Sodium-Glucose Transporter 2*

Substances

Hypoglycemic Agents
Sodium-Glucose Transporter 2

Grants and funding